Comments for SEPR - Stockpickr! Your Source for Stock Ideas

Comments for SEPR

Added By	Comments	Type	Date Added
stockerblog	The stock has a P/E of 37 , a PEG of 0.7	Love	March 31, 2008
Janet Bush	lost value	Hate	February 27, 2008
debmylet	pharma	Love	November 24, 2007
debmylet	pharma	Love	November 24, 2007
barrons2	Underperform - Price 27.39 on Sept. 11 by Friedman Billings Ramsey SEPR and GlaxoSmithKline announced a partnership for Lunesta (ex-U.S. name: Lunivia) in overseas markets: SEPR will receive a $20 million upfront payment, milestone payments of up to $155 million and tiered double-digit royalties. SEPR submitted a [European Union] filing earlier this year; approval expected 2H08. We are raising our revenue estimates to reflect royalties and milestone payments related to ex-U.S. Lunivia sales; however, we're maintaining Underperform/26 target. We believe 3Q07 [will] be another challenging quarter for SEPR, with Lunesta prescriptions declining by 4% sequentially (despite heavy marketing expenditure)....Our new EPS estimate for '08 is $1.73 (up from $1.68), growing to $2.29 (from $2.23) in 2011.	Love	September 15, 2007
jeffri12	price, close to 52 week low	Love	August 21, 2007
jackmchugh	poor management	Hate	July 12, 2007
supratrade	Ratings change: neutral, Price target: USD 53	Love	April 05, 2007
LatticeworkInvesting	Potential takeover target	Love	January 22, 2007
eddie c	3 successful money making products, unusal for a bio-tech. could be a takeover candicate	Love	January 17, 2007